A Randomized Controlled Trial of Rituximub versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)

Grant

Date/time Interval

  • April 2, 2013 - April 1, 2018
  • Awarded By

    Total Award Amount

  • 106731.00
  • Direct Costs

  • 84709.00
  • Sponsor Award Id

  • Contributor

  • Rizk, Dana   Principal Investigator